基因组学与应用生物学

参考文献

Alixpanabières C.,and Pantel K.,2016,Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy,Cancer Discovery,6(5):479

Bettegowda C.,Sausen M.,Leary R.J.,Kinde I.,Wang Y.,A-grawal N.,Bartlett B.R.,Wang H.,Luber B.,Alani R.M.,Antonarakis E.S.,Azad N.S.,Bardelli A.,Brem H.,Cameron J.L.,Lee C.C.,Fecher L.A.,Gallia G.L.,Gibbs P.,Le D.,Giuntoli R.L.,Goggins M.,Hogarty M.D.,Holdhoff M.,Hong S.M.,Jiao Y.,Juhl H.H.,Kim J.J.,Siravegna G.,Laheru D.A.,Lauricella C.,Lim M.,Lipson E.J.,Marie S.K.,Netto G.J.,Oliner K.S.,Olivi A.,Olsson L.,Riggins G.J.,Sartore-Bianchi A.,Schmidt K.,Shih M.,Oba-Shinjo S.M.,Siena S.,Theodorescu D.,Tie J.,Harkins T.T.,Veronese S.,Wang T.L.,Weingart J.D.,Wolfgang C.L.,Wood L.D.,Xing D.,Hruban R.H.,Wu J.,Allen P.J.,Schmidt C.M.,Choti M.A.,Velculescu V.E.,Kinzler K.W.,Vogelstein B.,Papadopoulos N.,and Diaz L.A.Jr.,2014,Detection of circulating tumor DNA in early-and late-stage human malignancies,Sci.Transl.Med.,6(224):224ra24

Board R.E.,Wardley A.M.,Dixon J.M.,Armstrong A.C.,Howell S.,Renshaw L.,Donald E.,Greystoke A.,Ranson M.,Hughes A.,and Dive C.,2010,Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer,Breast Cancer Res.Treat.,120(2):461-467

Byron E.,and Pinder-Schenck M.,2014,Systemic and targeted therapies for early-stage lung cancer,Cancer Control,21(1):21-31

Dawson S.J.,Tsui D.W.,Murtaza M.,Biggs H.,Rueda O.M.,Chin S.F.,Dunning M.J.,Gale D.,Forshew T.,Mahler-A-raujo B.,Rajan S.,Humphray S.,Becq J.,Halsall D.,Wallis M.,Bentley D.,Caldas C.,and Rosenfeld N.,2013,Analysis of circulating tumor DNA to monitor metastatic breast cancer,N.Engl.J.Med.,368(13):1199-1209

Diaz L.A.Jr.,and Bardelli A.,2014,Liquid biopsies:genotyping circulating tumor DNA,J.Clin.Oncol.,32(6):579-586

Diaz L.A.Jr.,Sausen M.,Fisher G.A.,and Velculescu V.E.,2013,Insights into therapeutic resistance from wholegenome analyses of circulating tumor DNA,Oncotarget,4(10):1856-1857

Diaz L.A.Jr.,Williams R.T.,Wu J.,Kinde I.,Hecht J.R.,Berlin J.,Allen B.,Bozic I.,Reiter J.G.,Nowak M.A.,Kinzler K.W.,Oliner K.S.,and Vogelstein B.,2012,The molecular evolution of acquired resistance to targeted egfr blockade in colorectal cancers,Nature,486(7404):537-540

Diehl F.,Schmidt K.,Choti M.A.,Romans K.,Goodman S.,Li M.,Thornton K.,Agrawal N.,Sokoll L.,Szabo S.A.,Kinzler K.W.,Vogelstein B.,and Diaz L.A.Jr.,2008,Circulating mutant DNA to assess tumor dynamics,Nat.Med.,14(9):985-990

Goldstraw P.,Crowley J.,Chansky K.,Giroux D.J.,Groome P.A.,Rami-Porta R.,Postmus P.E.,Rusch V.,Sobin L.,and International Association for the Study of Lung Cancer International Staging Committee.,Participating Institutions.,2007,The IASLC lung cancer staging project:proposals for the revision of the TNM Stage groupingsin the forthcoming(seventh)edition of the TNM classification of malignant tumours,J.Thorac.Oncol.,2(8):706-714

Higgins M.J.,Jelovac D.,Barnathan E.,Blair B.,Slater S.,Powers P.,Zorzi J.,Jeter S.C.,Oliver G.R.,Fetting J.,Emens L.,Riley C.,Stearns V.,Diehl F.,Angenendt P.,Huang P.,Cope L.,Argani P.,Murphy K.M.,Bachman K.E.,Greshock J.,Wolff A.C.,and Park B.H.,2012,Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood,Clin.Cancer Res.,18(12):3462-3469

Jahr S.,Hentze H.,Englisch S.,Hardt D.,Fackelmayer F.O.,Hesch R.D.,and Knippers R.,2001,DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptoticand necrotic cells,Cancer Res.,61(4):1659-1665

Krebs M.G.,Metcalf R.L.,Carter L.,Brady G.,Blackhall F.H.,and Dive C.,2014,Molecular analysis of circulating tumour cells-biology and biomarkers,Nat.Rev.Clin.Oncol.,11(3):129-144

Leary R.J.,Sausen M.,Kinde I.,Papadopoulos N.,Carpten J.D.,Craig D.,O'Shaughnessy J.,Kinzler K.W.,Parmigiani G.,Vogelstein B.,Diaz L.A.Jr.,and Velculescu V.E.,2012,Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing,Sci.Transl.Med.,4(162):162ra154

Leary RJ.,Kinde I.,Diehl F.,Schmidt K.,Clouser C.,Duncan C.,Antipova A.,Lee C.,McKernan K.,De La Vega F.M.,Kinzler K.W.,Vogelstein B.,Diaz L.A.Jr.,and Velculescu V.E.,2010,Development of personalized tumor biomarkers using massively parallel sequencing,Sci.Transl.Med.,2(20):20ra14

Lecomte T.,Berger A.,Zinzindohoue F.,Micard S.,Landi B.,Blons H.,Beaune P.,Cugnenc P.H.,and Laurent-Puig P.,2002,Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis,Int.J.Cancer,100(5):542-548

Lipson E.J.,Velculescu V.E.,Pritchard T.S.,Sausen M.,Pardoll D.M.,Topalian S.L.,and Diaz L.A.Jr.,2014,Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade,J.Immunother Cancer,2(1):42

Lo Y.M.,Corbetta N.,Chamberlain P.F.,Rai V.,Sargent I.L.,Redman C.W.,and Wainscoat J.S.,1997,Presence of fetal DNA in maternal plasma and serum,Lancet,350(9076):485-487

Lo Y.M.,Zhang J.,Leung T.N.,and Lau T.K.,Chang A.M.,and Hjelm N.M.,1999,Rapid clearance of fetal DNA from maternal plasma,Am.J.Hum.Genet.,64(1):218-224

Madic J.,Kiialainen A.,Bidard F.C.,Birzele F.,Ramey G.,Leroy Q.,Rio Frio T.,Vaucher I.,Raynal V.,Bernard V.,Lermine A.,Clausen I.,Giroud N.,Schmucki R.,Milder M.,Horn C.,Spleiss O.,Lantz O.,Stern M.H.,Pierga J.Y.,Weisser M.,and Lebofsky R.,2015,Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients,Int.J.Cancer,136(9):2158-2165

McBride D.J.,Orpana A.K.,Sotiriou C.,Joensuu H.,Stephens P.J.,Mudie L.J.,H覿m覿l覿inen E.,Stebbings L.A.,Andersson L.C.,Flanagan A.M.,Durbecq V.,Ignatiadis M.,Kallioniemi O.,Heckman C.A.,Alitalo K.,Edgren H.,Futreal P.A.,Stratton M.R.,and Campbell P.J.,2010,Use of cancerspecifc genomic rearrangements to quantify disease burden in plasma from patients with solid tumors,Genes Chromosomes Cancer,49(11):1062-1069

Murtaza M.,Dawson S.J.,Tsui D.W.,Gale D.,Forshew T.,Piskorz A.M.,Parkinson C.,Chin S.F.,Kingsbury Z.,Wong A.S.,Marass F.,Humphray S.,Hadfield J.,Bentley D.,Chin T.M.,Brenton J.D.,Caldas C.,and Rosenfeld N.,2013,Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA,Nature,497(7447):108-112

Nagata S.,Hanayama R.,and Kawane K.,2010,Autoimmunity and the clearance of dead cells,Cell,140(5):619-630

Narayan A.,Carriero N.J.,Gettinger S.N.,Kluytenaar J.,Kozak K.R.,Yock T.I.,Muscato N.E.,Ugarelli P.,Decker R.H.,and Patel A.A.,2012,Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing,Cancer Res.,72(14):3492-3498

Newman A.M.,Bratman S.V.,To J.,Wynne J.F.,Eclov N.C.,Modlin L.A.,Liu C..,Neal J.W.,Wakelee H.A.,Merritt R.E.,Shrager J.B.,Loo B.W.Jr.,Alizadeh A.A.,and Diehn M.,2014,An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage,Nat.Med.,20(5):548-554

Olsson E.,Winter C.,George A.,Chen Y.,Howlin J.,Tang M.H.,Dahlgren M.,Schulz R.,Grabau D.,van Westen D.,Fern觟M.,Ingvar C.,Rose C.,Bendahl P.O.,Rydén L.,Borgé.,Gruvberger-Saal S.K.,Jernstr觟m H..,and Saal L.H.,2015,Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease,EMBO Mol.Med.,7(8):1034-1047

Punnoose E.A.,Atwal S.,Liu W.,Raja R.,Fine B.M.,Hughes B.G.,Hicks R.J.,Hampton G.M.,Amler L.C.,Pirzkall A.,and Lackner M.R.,2012,Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer:association with clinical endpoints in a phaseⅡclinical trial of pertuzumab and erlotinib,Clin.Cancer Res.,18(8):2391-2401

Reinert T.,Schler L.V.,Thomsen R.,Tobiasen H.,Vang S.,Nordentoft I.,Lamy P.,Kannerup A.S.,Mortensen F.V.,Stribolt K.,Hamilton-Dutoit S.,Nielsen H.J..,Laurberg S.,Pallisgaard N.,Pedersen J.S.,覫rntoft T.F.,and Andersen C.L.,2015,Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery,Gut.,65(4):625-634

Rothe F.,Laes J.,Lambrechts D.,Smeets D.,Vincent D.,Maetens M.,Fumagalli D.,Michiels S.,Drisis S.,Moerman C.,Detiffe J.P.,Larsimont D.,Awada A.,Piccart M.,Sotiriou C.,and Ignatiadis M.,2014,Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer,Ann.Oncol.,25(10):1959-1965

Serrano M.J.,Ortega F.G.,Alvarez-Cubero M.J.,Nadal R.,Sanchez-Rovira P.,Salido M.,Rodríguez M.,García-Puche J.L.,Delgado-Rodriguez M.,SoléF.,García M.A.,Perán M.,Rosell R.,Marchal J.A.,and Lorente J.A.,2014,EMTand EGFR in CTCs cytokeratin negative nonmetastatic breast cancer,Oncotarget,5(17):7486-7497

Shah S.P.,Morin R.D.,Khattra J.,Prentice L.,Pugh T.,Burleigh A.,Delaney A.,Gelmon K.,Guliany R.,Senz J.,Steidl C.,Holt R.A.,Jones S.,Sun M.,Leung G.,Moore R.,Severson T.,Taylor G.A.,Teschendorff A.E.,Tse K.,Turashvili G.,Varhol R.,Warren R.L.,Watson P.,Zhao Y.,Caldas C.,Huntsman D.,Hirst M.,Marra M.A.,and Aparicio S.,2009,Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution,Nature,461(7265):809-813

Siravegna G.,Mussolin B.,Buscarino M.,Corti G.,Cassingena A.,Crisafulli G.,Ponzetti A.,Cremolini C.,Amatu A.,Lauricella C.,Lamba S.,Hobor S.,Avallone A.,Valtorta E.,Rospo G.,Medico E.,Motta V.,Antoniotti C.,Tatangelo F.,Bellosillo B.,Veronese S.,Budillon A.,Montagut C.,Racca P.,Marsoni S.,Falcone A.,Corcoran R.B.,Di Nicolantonio F.,Loupakis F.,Siena S.,Sartore-Bianchi A.,and Bardelli A.,2015,Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients,Nat.Med.,21(7):795-801

Swarup V.,and Rajeswari M.R.,2007,Circulating(cell-free)nucleic acids-A promising,non-invasive tool for early detection of several human diseases,FEBS Lett.,581(5):795-799

Thierry A.R.,Mouliere F.,El Messaoudi S.,Mollevi C.,LopezCrapez E.,Rolet F.,Gillet B.,Gongora C.,Dechelotte P.,Robert B.,Del Rio M.,Lamy P.J.,Bibeau F.,Nouaille M.,Loriot V.,Jarrousse A.S.,Molina F.,Mathonnet M.,Pezet D.,and Ychou M.,2014,Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA,Nat.Med.,20(4):430-435

Tie J.,Wang Y.,Tomasetti C.,Li L.,Springer S.,Kinde I.,Sil liman N.,Tacey M.,Wong H.L.,Christie M.,Kosmider S.,Skinner I.,Wong R.,Steel M.,Tran B.,Desai J.,Jones I.,Haydon A.,Hayes T.,Price T.J.,Strausberg R.L.,Diaz L.A.Jr.,Papadopoulos N.,Kinzler K.W.,Vogelstein B.,and Gibbs P.,2016,Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stageⅡcolon cancer,Sci.Transl.Med.,8(346):346ra92

Vakiani E.,Janakiraman M.,Shen R.,Sinha R.,Zeng Z.,Shia J.,Cercek A.,Kemeny N.,D'Angelica M.,Viale A.,Heguy A.,Paty P.,Chan T.A.,Saltz L.B.,Weiser M.,and Solit D.B.,2012,Comparative genomic analysis of primary versus metastatic colorectal carcinomas,J.Clin.Oncol.,30(24):2956-2962

Yong E.,2014,Cancer biomarkers:written in blood,Nature,511(7511):524-526